During a time of increasing demand for tools that empower providers to create more effective and cost-effective prescribing for their patients, Blake Keller, PharmD has joined Nashville-based RxGenomix as Chief Operating Officer. Blake is already at work strengthening RxGenomix’s proprietary precision medicine offerings, operating procedures, and supply chain in anticipation of significant growth in 2019. His role will focus on all aspects of product diversification, service delivery strategy and accelerating the development of the RxGenomix infrastructure and revenue generation channels.